Extracellular calreticulin is present in the joints of patients with rheumatoid arthritis and inhibits FasL (CD95L)-mediated apoptosis of T cells.
OBJECTIVE: The binding of FasL (CD95L) to its receptor, Fas (CD95), induces apoptosis. Studies have shown that in patients with rheumatoid arthritis (RA), T lymphocytes are resistant to FasL-induced apoptosis in vivo but are susceptible to FasL-induced apoptosis in vitro. Dysfunction in this mechan...
Hlavní autoři: | Tarr, J, Winyard, P, Ryan, B, Harries, L, Haigh, R, Viner, N, Eggleton, P |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2010
|
Podobné jednotky
-
Fas/FasL promoter gene polymorphism in patients with rheumatoid arthritis
Autor: A. Berdeli, a další
Vydáno: (2012-12-01) -
The Fas/FasL System in Reproduction: Survival and Apoptosis
Autor: Gil Mor, a další
Vydáno: (2002-01-01) -
A mechanism of release of calreticulin from cells during apoptosis.
Autor: Tarr, J, a další
Vydáno: (2010) -
Alteration of Regulation of Fas/FasL Mediated Apoptosis in Gastric Cancer
Autor: Reggie García Robles, a další
Vydáno: (2009-04-01) -
Leucemia mielóide crônica e o sistema Fas-FasL Chronic myeloid leukemia and the Fas-FasL system
Autor: Ana Paula F. Bergantini, a další
Vydáno: (2005-06-01)